APO RESEARCH · REPORT
Silymarin
Silymarin is a flavonolignans extracted from the milk thistle Silybum marianum (L.) gaernt. Silymarin has been shown to possess various pharmacological properties like hepatoprotective, antioxidant, antiinflammatory, anticancer, and cardioprotective activities.
Product & engineering
Understand the product.
Silymarin is a flavonolignans extracted from the milk thistle Silybum marianum (L.) gaernt. Silymarin has been shown to possess various pharmacological properties like hepatoprotective, antioxidant, antiinflammatory, anticancer, and cardioprotective activities.
Selected research
Market Structure
Global Silymarin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Silymarin is a flavonolignans extracted from the milk thistle Silybum marianum (L.) gaernt. Silymarin has been shown to possess various pharmacological properties like hepatoprotective, antioxidant, antiinflammatory, anticancer, and cardioprotective activities.
The top players cover LIVERD PHARMA, TY Pharmaceutical, KEB Biotech, etc. The Top 3 players in Global Silymarin market revenue was 50.46% in 2019, while the share of top 5 players was 61.99%. TY Pharmaceutical is the leading supplier of Silymarin, the production of which reached 438 MT in 2019, accounting for about 18.81% of the Global market. Market concentration is high. Except policy affect, downstream demand is the key influence factor to the market.
This report provides an overview of the global Silymarin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Silymarin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Silymarin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Silymarin market size, projected growth trends, production technologies, key applications, and end-use industries.
Silymarin Segment by Company
LIVERD PHARMA
Huacheng Pharmaceutical
TY Pharmaceutical
Teva API
KEB Biotech
Shengbo Silymarin
Panjin Fengrui
Jiaherb
Silymarin Segment by Type
Silymarin Extracted by Acetone
Silymarin Extracted by Ethyl Acetate
Silymarin Extracted by Ethanol
Water Soluble Silymarin
Silymarin Segment by Application
Pharma and Healthcare
Food Additives
Cosmetic and Skin Care
Others
Silymarin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Silymarin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Silymarin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Silymarin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Silymarin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Silymarin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Silymarin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Silymarin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Silymarin Extracted by Acetone
- Silymarin Extracted by Ethyl Acetate
- Silymarin Extracted by Ethanol
- Water Soluble Silymarin
Applications
- Pharma and Healthcare
- Food Additives
- Cosmetic and Skin Care
- Others
Companies covered
- LIVERD PHARMA
- Huacheng Pharmaceutical
- TY Pharmaceutical
- Teva API
- KEB Biotech
- Shengbo Silymarin
- Panjin Fengrui
- Jiaherb
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Silymarin Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Silymarin Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Silymarin Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Silymarin Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Silymarin Market Dynamics
- 2.1 Silymarin Industry Trends
- 2.2 Silymarin Industry Drivers
- 2.3 Silymarin Industry Opportunities and Challenges
- 2.4 Silymarin Industry Restraints
3 Silymarin Market by Manufacturers
- 3.1 Global Silymarin Revenue by Manufacturers (2021-2026)
- 3.2 Global Silymarin Sales by Manufacturers (2021-2026)
- 3.3 Global Silymarin Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Silymarin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Silymarin Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Silymarin Manufacturers, Product Type & Application
- 3.7 Global Silymarin Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Silymarin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Silymarin Players Market Share by Revenue in 2025
- 3.8.3 2025 Silymarin Tier 1, Tier 2, and Tier 3
4 Silymarin Market by Type
- 4.1 Silymarin Type Introduction
- 4.1.1 Silymarin Extracted by Acetone
- 4.1.2 Silymarin Extracted by Ethyl Acetate
- 4.1.3 Silymarin Extracted by Ethanol
- 4.1.4 Water Soluble Silymarin
- 4.2 Global Silymarin Sales by Type
- 4.2.1 Global Silymarin Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Silymarin Sales by Type (2021-2032)
- 4.2.3 Global Silymarin Sales Market Share by Type (2021-2032)
- 4.3 Global Silymarin Revenue by Type
- 4.3.1 Global Silymarin Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Silymarin Revenue by Type (2021-2032)
- 4.3.3 Global Silymarin Revenue Market Share by Type (2021-2032)
5 Silymarin Market by Application
- 5.1 Silymarin Application Introduction
- 5.1.1 Pharma and Healthcare
- 5.1.2 Food Additives
- 5.1.3 Cosmetic and Skin Care
- 5.1.4 Others
- 5.2 Global Silymarin Sales by Application
- 5.2.1 Global Silymarin Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Silymarin Sales by Application (2021-2032)
- 5.2.3 Global Silymarin Sales Market Share by Application (2021-2032)
- 5.3 Global Silymarin Revenue by Application
- 5.3.1 Global Silymarin Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Silymarin Revenue by Application (2021-2032)
- 5.3.3 Global Silymarin Revenue Market Share by Application (2021-2032)
6 Global Silymarin Sales by Region
- 6.1 Global Silymarin Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Silymarin Sales by Region (2021-2032)
- 6.2.1 Global Silymarin Sales by Region (2021-2026)
- 6.2.2 Global Silymarin Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Silymarin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Silymarin Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Silymarin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Silymarin Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Silymarin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Silymarin Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Silymarin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Silymarin Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Silymarin Revenue by Region
- 7.1 Global Silymarin Revenue by Region
- 7.1.1 Global Silymarin Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Silymarin Revenue by Region (2021-2026)
- 7.1.3 Global Silymarin Revenue by Region (2027-2032)
- 7.1.4 Global Silymarin Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Silymarin Revenue (2021-2032)
- 7.2.2 North America Silymarin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Silymarin Revenue (2021-2032)
- 7.3.2 Europe Silymarin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Silymarin Revenue (2021-2032)
- 7.4.2 Asia-Pacific Silymarin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Silymarin Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Silymarin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 LIVERD PHARMA
- 8.1.1 LIVERD PHARMA Company Information
- 8.1.2 LIVERD PHARMA Business Overview
- 8.1.3 LIVERD PHARMA Silymarin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 LIVERD PHARMA Silymarin Product Portfolio
- 8.1.5 LIVERD PHARMA Recent Developments
- 8.2 Huacheng Pharmaceutical
- 8.2.1 Huacheng Pharmaceutical Company Information
- 8.2.2 Huacheng Pharmaceutical Business Overview
- 8.2.3 Huacheng Pharmaceutical Silymarin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Huacheng Pharmaceutical Silymarin Product Portfolio
- 8.2.5 Huacheng Pharmaceutical Recent Developments
- 8.3 TY Pharmaceutical
- 8.3.1 TY Pharmaceutical Company Information
- 8.3.2 TY Pharmaceutical Business Overview
- 8.3.3 TY Pharmaceutical Silymarin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 TY Pharmaceutical Silymarin Product Portfolio
- 8.3.5 TY Pharmaceutical Recent Developments
- 8.4 Teva API
- 8.4.1 Teva API Company Information
- 8.4.2 Teva API Business Overview
- 8.4.3 Teva API Silymarin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Teva API Silymarin Product Portfolio
- 8.4.5 Teva API Recent Developments
- 8.5 KEB Biotech
- 8.5.1 KEB Biotech Company Information
- 8.5.2 KEB Biotech Business Overview
- 8.5.3 KEB Biotech Silymarin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 KEB Biotech Silymarin Product Portfolio
- 8.5.5 KEB Biotech Recent Developments
- 8.6 Shengbo Silymarin
- 8.6.1 Shengbo Silymarin Company Information
- 8.6.2 Shengbo Silymarin Business Overview
- 8.6.3 Shengbo Silymarin Silymarin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Shengbo Silymarin Silymarin Product Portfolio
- 8.6.5 Shengbo Silymarin Recent Developments
- 8.7 Panjin Fengrui
- 8.7.1 Panjin Fengrui Company Information
- 8.7.2 Panjin Fengrui Business Overview
- 8.7.3 Panjin Fengrui Silymarin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Panjin Fengrui Silymarin Product Portfolio
- 8.7.5 Panjin Fengrui Recent Developments
- 8.8 Jiaherb
- 8.8.1 Jiaherb Company Information
- 8.8.2 Jiaherb Business Overview
- 8.8.3 Jiaherb Silymarin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Jiaherb Silymarin Product Portfolio
- 8.8.5 Jiaherb Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Silymarin Value Chain Analysis
- 9.1.1 Silymarin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Silymarin Production Mode & Process
- 9.2 Silymarin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Silymarin Distributors
- 9.2.3 Silymarin Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst